Article Type
Changed
Fri, 01/04/2019 - 11:06
Display Headline
Community Oncology Podcast - Axitinib and sorafenib in advanced renal cell carcinoma.

Editor-in-Chief Dr. David H. Henry takes you on an audio tour of the July issue including discussions of an original research report on the impact of depression on cancer comorbidity and this month's Community Translation: Axitinib and sorafenib in second-line treatment of advanced renal cell carcinoma.

Author and Disclosure Information

Audio / Podcast
Publications
Topics
Legacy Keywords
Dr. David H. Henry, impact of depression on cancer comorbidity, Axitinib and sorafenib, renal cell carcinoma
Audio / Podcast
Audio / Podcast
Author and Disclosure Information

Author and Disclosure Information

Editor-in-Chief Dr. David H. Henry takes you on an audio tour of the July issue including discussions of an original research report on the impact of depression on cancer comorbidity and this month's Community Translation: Axitinib and sorafenib in second-line treatment of advanced renal cell carcinoma.

Editor-in-Chief Dr. David H. Henry takes you on an audio tour of the July issue including discussions of an original research report on the impact of depression on cancer comorbidity and this month's Community Translation: Axitinib and sorafenib in second-line treatment of advanced renal cell carcinoma.

Publications
Publications
Topics
Article Type
Display Headline
Community Oncology Podcast - Axitinib and sorafenib in advanced renal cell carcinoma.
Display Headline
Community Oncology Podcast - Axitinib and sorafenib in advanced renal cell carcinoma.
Legacy Keywords
Dr. David H. Henry, impact of depression on cancer comorbidity, Axitinib and sorafenib, renal cell carcinoma
Legacy Keywords
Dr. David H. Henry, impact of depression on cancer comorbidity, Axitinib and sorafenib, renal cell carcinoma
Article Source

PURLs Copyright

Inside the Article